Viking Therapeutics
VKTX
VKTX
196 hedge funds and large institutions have $1.45B invested in Viking Therapeutics in 2023 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 61 increasing their positions, 54 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
196
Holders Change
+17
Holders Change %
+9.5%
% of All Funds
2.87%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
47
Increased
61
Reduced
54
Closed
30
Calls
$65.7M
Puts
$29.3M
Net Calls
+$36.4M
Net Calls Change
+$10.6M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$39.7M |
| 2 |
Pictet Asset Management
Carouge,
Switzerland
|
+$12.7M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$12.3M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$10.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$10.1M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$22.1M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$22.1M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$13.5M |
| 4 |
State Street
Boston,
Massachusetts
|
-$12.6M |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$9.39M |
